Board Changes

Summary by AI BETAClose X

CRISM Therapeutics Corporation announces the resignation of Dr. Nermeen Varawalla from the Board of Directors, who served as Non-Executive Chair since the company's AIM listing in May 2024. Andrew Webb will continue as Interim Executive Chair while a search for a successor is underway, with Gerry Beaney taking over as Chair of the Remuneration Committee. The company expressed gratitude for Dr. Varawalla's contributions and noted that the search for a new Chair aligns with CRISM's progression towards its phase 2 clinical trial and future commercialisation.

Disclaimer*

UK 100

Latest directors dealings